Global Sexual Health Supplements Market Outlook & Forecasts 2023-2028: Proliferation of E-commerce and Product Launches in Multiple Dosage Forms Driving Access and Growth
July 12, 2023 04:03 ET
|
Research and Markets
Dublin, July 12, 2023 (GLOBE NEWSWIRE) -- The "Sexual Health Supplements Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.The global...
Sexual Wellness Market hit USD 75.5 billion by 2032, says Global Market Insights Inc.
June 28, 2023 05:00 ET
|
Global Market Insights Inc.
Selbyville, Delaware, June 28, 2023 (GLOBE NEWSWIRE) -- Sexual Wellness Market size is expected to surpass USD 75.5 billion by 2032. The sexual wellness industry has experienced significant...
Mangoceuticals Signs Deal with BarStool Sports to Market Mango on Popular “Only Stans” Podcast
June 08, 2023 09:00 ET
|
Mangoceuticals, Inc.
Dallas, Texas, June 08, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing and selling a variety of men’s health and...
Erectile Dysfunction Drugs Market to Reach $5.1 Billion, Globally, by 2032 at 6.5% CAGR: Allied Market Research
May 11, 2023 10:13 ET
|
Allied Market Research
Portland, OR, May 11, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Erectile Dysfunction Drugs Market By Product (Sildenafil, Avanfil, Tadalafil, Udenafil, and...
Over 20 Million Suffer From Peripheral Neuropathy, St. Pete Medical Group Aims to Help
December 14, 2022 12:30 ET
|
St. Pete Medical Group
ST. PETERSBURG, Fla., Dec. 14, 2022 (GLOBE NEWSWIRE) -- St. Pete Medical Group and Clearwater Medical Group were featured on 10 Tampa Bay's Great Day Live. Dr. Alex Spinoso announced their mission...
Zylö Receives $263,000 NIH Phase I Grant to Develop a Topical Viagra® for ED
September 16, 2022 08:30 ET
|
Zylö Therapeutics
Funds to be used to optimize a formulation and demonstrate comparable efficacy to oral Viagra GREENVILLE, SC, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the Z-pod®...
Oncotelic Presenting Data for OT101 Against Diffuse Intrinsic Pontine Glioma (DIPG) at the 2022 Society for Neuro-Oncology (SNO) Annual Meeting
September 14, 2022 08:15 ET
|
Oncotelic Therapeutics, Inc.
AGOURA HILLS, Calif., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC), developer of treatments for rare and orphan indications, including...
ONCOTELIC ACQUIRES FAST TO MARKET LATE-STAGE DRUG CANDIDATE FOR PARKINSON DISEASE, ERECTILE DYSFUNCTION, AND FEMALE SEXUAL DYSFUNCTION.
October 04, 2021 07:00 ET
|
Oncotelic Therapeutics, Inc.
AGOURA HILLS, Calif., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC), executed an exclusive licensing agreement on September 30, 2021,...
ONCOTELIC TO ACQUIRE LATE-STAGE DRUG CANDIDATE FOR PARKINSON DISEASE, ERECTILE DYSFUNCTION, AND FEMALE SEXUAL DYSFUNCTION.
September 01, 2021 12:00 ET
|
Oncotelic Therapeutics, Inc.
AGOURA HILLS, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ("Oncotelic" or the "Company") (OTCQB:OTLC), executed a binding term sheet with Autotelic Inc. to license AL-101...
Zylö Receives $1,700,000 NIH Phase II Grant to Advance Erectile Dysfunction Program into Human Trials
July 20, 2021 09:00 ET
|
Zylö Therapeutics
Funds to be used for scale-up, implementation of cGMP quality system, and pre-IND FDA meeting GREENVILLE, SC, July 20, 2021 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the...